Trial · NCT01999582
Results by group102
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 102
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection | 15204.31 | Standard Deviation 7096.55 | day*ng/mL | |
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection | 11269.14 | Standard Deviation 1839.92 | day*ng/mL | |
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 2: Sotatercept 0.2 mg/kg IV Injection | 28647.03 | Standard Deviation 10332.19 | day*ng/mL | |
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 2: Sotatercept 0.26 mg/kg SC Injection | 10327.98 | Standard Deviation 8065.12 | day*ng/mL | |
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection | 15886.83 | Standard Deviation 4212.12 | day*ng/mL | |
| Area Under the Serum Concentration-Time Curve Over Dosing Interval (AUC14d) (14 Days) | Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection | 21982.9 | Standard Deviation 5125.4 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection | 38361.5 | Standard Deviation 8589.34 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection | 41500.36 | Standard Deviation 13647.28 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 2: Sotatercept 0.2 mg/kg IV Injection | 94106.54 | Standard Deviation 37204.17 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 2: Sotatercept 0.26 mg/kg SC Injection | 36065.09 | Standard Deviation 22817 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection | 33173.4 | Standard Deviation 8709.16 | day*ng/mL | |
| Area Under the Serum Concentration- Time Curve Over From Day 1 to Day 28 (AUC28d) | Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection | 60497.8 | Standard Deviation 14623.13 | day*ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection | 2567.6 | Standard Deviation 1093.73 | ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection | 1024.27 | Standard Deviation 145.8 | ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 2: Sotatercept 0.2 mg/kg IV Injection | 4623.61 | Standard Deviation 1620.66 | ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 2: Sotatercept 0.26 mg/kg SC Injection | 963.05 | Standard Deviation 659.65 | ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection | 3155.53 | Standard Deviation 1861.07 | ng/mL | |
| Maximum Observed Serum Concentration Obtained From the First Dose (Cmax14d) | Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection | 1993.58 | Standard Deviation 375.54 | ng/mL | |
| Maximum Observed Serum Concentration (Cmax28d) Obtained From the Combined First 2 Doses | Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection | 3557.93 | Standard Deviation 699.19 | ng/mL | |
| Maximum Observed Serum Concentration (Cmax28d) Obtained From the Combined First 2 Doses | Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection | 3868.83 | Standard Deviation 3614.89 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01999582/results